Results 351 to 360 of about 9,783,797 (388)
Some of the next articles are maybe not open access.
Natural products as sources of new drugs over the period 1981-2002.
Journal of Natural Products, 2003This review is an updated and expanded version of a paper that was published in this journal in 1997. The time frame has been extended in both directions to include the 22 years from 1981 to 2002, and a new secondary subdivision related to the natural ...
D. Newman, G. Cragg, K. Snader
semanticscholar +1 more source
Monitoring of Drug-Drug and Drug-Food Interactions
American Journal of Health-System Pharmacy, 1988A program for detecting and preventing potentially serious drug-drug and drug-food interactions is described. Two clinical pharmacists developed drug interaction alert (DIA) cards for each potential interaction to be monitored. The cards contain information about the proposed mechanism and potential result of the interaction, as well as information ...
Susan M. Garabedian-Ruffalo +3 more
openaire +3 more sources
Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs
The American Journal of Medicine, 1986Nonsteroidal anti-inflammatory drugs may cause a number of drug interactions. They can displace other drugs from serum proteins, and some can affect the metabolism or decrease the renal elimination of other drugs. In addition, they can attenuate the pharmacologic effect of other drugs, such as diuretic and antihypertensive agents, without affecting ...
John H. Greist +3 more
openaire +6 more sources
Drug Discovery Today, 2001
Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance and biological relevance of new molecules reported in the
openaire +6 more sources
Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance and biological relevance of new molecules reported in the
openaire +6 more sources
Drug–drug interaction with statins
Expert Review of Clinical Pharmacology, 20083-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire +3 more sources
Drug Repurposing Based on Drug–Drug Interaction
Chemical Biology & Drug Design, 2014Given the high risk and lengthy procedure of traditional drug development, drug repurposing is gaining more and more attention. Although many types of drug information have been used to repurpose drugs, drug–drug interaction data, which imply possible physiological effects or targets of drugs, remain unexploited.
Ping Wu +3 more
openaire +3 more sources
A drug-to-drug interaction package
Computer Methods and Programs in Biomedicine, 1989This paper describes an electronic database for handling the interactions between active principles administered to various patients. The computer used is a personal computer with adequate mass memory, software, and data obtained from pharmacological sources.
PINCIROLI, FRANCESCO, POZZI, GIUSEPPE
openaire +4 more sources
Drug-Drug Interactions of Antimalarial Drugs
2018Malaria is the most important parasitic disease of humans accounting for high morbidity and mortality rates in the tropical and subtropical countries of Africa, Asia, and the Americas. Combination chemotherapy is recommended for treatment of acute uncomplicated malaria as a result of widespread drug resistance.
Tunde Balogun +3 more
openaire +2 more sources
Drug–drug interactions involving new antiretroviral drugs and drug classes
Current Opinion in Infectious Diseases, 2009The aim of this article is to review the available data on new antiretroviral agents and the drug-drug interactions studied so far.Several new drugs have been recently approved or are under development for the treatment of HIV infection. The pharmacokinetics of these agents is being studied to provide information about safety and efficacy, and ...
Marta Sousa +2 more
openaire +3 more sources
Iron as a Drug and Drug–Drug Interactions
2009• Bioavailabiltiy of oral iron may be enhanced in the presence of reducing agents such as ascorbic acid.
Teresa V. Lewis, Tracy M. Hagemann
openaire +2 more sources